Prophylactic Treatment to reduce risk of Contrast induced nephropathy

Sharing is caring!

Prophylactic Treatment to reduce risk of Contrast induced nephropathy

What are the historical prophylactic therapies that reduce cin risk and how effective are they?

Several classes of pharmacologic agents have been investigated to provide prophylaxis from contrast nephropathy.

The following agents failed in prospective trials and are not recommended:

• Theophylline has been examined as a prophylactic treatment for CIN because of its effect on renal vasodilation through non-selective blockage of the adenosine receptor; however, it is not generally recommended because of its lack of evidence in large, randomized, controlled trials and potential drug-related toxicity when administered intravenously (such as ventricular arrhythmias, seizures, and shock)

• Mannitol

• Furosemide

• Dopamine

• Atrial natriuretic peptide

• Fenoldopam

• Endothelin receptor antagonist

Sharing is caring!

You cannot copy content of this page

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856
Scroll to Top